Patents by Inventor Jeffrey Leid

Jeffrey Leid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multivalent vaccine protection from infection
    Patent number: 9265820
    Abstract: Vaccine formulations effective against Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA) are disclosed, as well as methods of using the vaccine formulations in the treatment and prevention of Staphylococcus aureus infections in a subject.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: February 23, 2016
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Mark Shirtliff, Janette Harro, Jeffrey Leid
  • MULTIVALENT VACCINE PROTECTION FROM STAPHYLOCOCCUS AUREUS INFECTION
    Publication number: 20150024000
    Abstract: Vaccine formulations effective against Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA) are disclosed, as well as methods of using the vaccine formulations in the treatment and prevention of Staphylococcus aureus infections in a subject.
    Type: Application
    Filed: March 5, 2013
    Publication date: January 22, 2015
    Applicant: University of Maryland, Baltimore
    Inventors: Mark Shirtliff, Janette Harro, Jeffrey Leid
  • Multivalent vaccine protection from infection
    Patent number: RE48137
    Abstract: Vaccine formulations effective against Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA) are disclosed, as well as methods of using the vaccine formulations in the treatment and prevention of Staphylococcus aureus infections in a subject.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: August 4, 2020
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Mark Shirtliff, Janette Harro, Jeffrey Leid